The role of endothelium in cardiovascular homeostasis and diseases
- PMID: 7523767
- DOI: 10.1097/00005344-199322004-00002
The role of endothelium in cardiovascular homeostasis and diseases
Abstract
Key discoveries in the past decade have revealed that the vascular endothelium is an important regulatory organ that is involved in maintaining cardiovascular homeostasis in health and contributes significantly to the pathomechanism of several cardiovascular diseases. Occupying a strategically important location between circulating blood and tissues and having the ability to respond to changes in its physical, chemical, and humoral environment by the production of a host of biologically active substances, the normal endothelium modulates the tone of underlying vascular smooth muscle, maintains a nonadhesive luminal surface, and mediates hemostasis, cellular proliferation, and inflammatory and immune mechanisms in the vascular wall. Modulation of smooth-muscle tone is mediated by the synthesis release of endothelium-derived relaxing [PGI2, EDRF(NO), and EDHF] and contracting factors (arachidonic acid metabolites, endothelin-1, and angiotensin II). Anticoagulant, fibrinolytic, and antithrombotic properties contribute to the maintenance of the fluidity of blood. Injury or activation (by cytokines) of endothelial cells disrupts these normal regulatory mechanisms and results in morphologic and functional alterations (phenotypic changes) commonly defined as endothelial dysfunction. Clinically, the "syndrome" of endothelial cell dysfunction can be described as generalized or localized vasospasm, thrombosis, atherosclerosis, and restenosis. Although its importance is clearly established, no drugs used today were originally targeted for the treatment of endothelial dysfunction. Recent studies, however, showed that some existing therapies (e.g., angiotensin-converting enzyme inhibitors) may protect the endothelium. Novel diagnostic techniques and innovative therapeutic strategies, based on the already known molecular mechanisms of endothelial dysfunction, are briefly outlined. Further knowledge of the pathobiology of the impaired endothelium will contribute to unraveling some of the remaining mysteries of many cardiovascular diseases and will enable us to design novel therapies to prevent and treat them.
Similar articles
-
The endothelium in health and in cardiovascular disease.P R Health Sci J. 1997 Jun;16(2):136-41. P R Health Sci J. 1997. PMID: 9285990 Review.
-
Endothelium-derived relaxing and contracting factors.J Cell Biochem. 1991 May;46(1):27-36. doi: 10.1002/jcb.240460106. J Cell Biochem. 1991. PMID: 1874796 Review.
-
The endothelium in acute coronary syndromes.Eur Heart J. 1998 Apr;19 Suppl C:C30-8. Eur Heart J. 1998. PMID: 9597423 Review.
-
Biology of the impaired endothelium.Am J Cardiol. 1991 Nov 4;68(12):6C-8C. doi: 10.1016/0002-9149(91)90217-9. Am J Cardiol. 1991. PMID: 1951106 Review.
-
[The role of blood vessel endothelium in vascular smooth muscle reactivity to biologically active substances and drugs].Srp Arh Celok Lek. 1989 Nov-Dec;117(11-12):799-810. Srp Arh Celok Lek. 1989. PMID: 2490997 Serbian.
Cited by
-
Effects of Piper sarmentosum Roxb. on hypertension and diabetes mellitus: A systematic review and meta-analysis.Front Pharmacol. 2022 Aug 25;13:976247. doi: 10.3389/fphar.2022.976247. eCollection 2022. Front Pharmacol. 2022. PMID: 36091787 Free PMC article.
-
Apelin elevates blood pressure in ICR mice with L‑NAME‑induced endothelial dysfunction.Mol Med Rep. 2013 May;7(5):1371-5. doi: 10.3892/mmr.2013.1378. Epub 2013 Mar 15. Mol Med Rep. 2013. PMID: 23525196 Free PMC article.
-
Selection of different endothelialization modes and different seed cells for tissue-engineered vascular graft.Bioact Mater. 2021 Feb 6;6(8):2557-2568. doi: 10.1016/j.bioactmat.2020.12.021. eCollection 2021 Aug. Bioact Mater. 2021. PMID: 33665496 Free PMC article. Review.
-
Enhanced endothelial activity reflected in cutaneous blood flow oscillations of athletes.Eur J Appl Physiol. 2003 Sep;90(1-2):16-22. doi: 10.1007/s00421-003-0867-6. Epub 2003 May 29. Eur J Appl Physiol. 2003. PMID: 12783233 Clinical Trial.
-
Effect of nutritional restriction in early pregnancy on isolated femoral artery function in mid-gestation fetal sheep.J Physiol. 2003 Dec 1;553(Pt 2):637-47. doi: 10.1113/jphysiol.2003.045278. Epub 2003 Aug 29. J Physiol. 2003. PMID: 12949230 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous